Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
kate.thomson@cardiov.ox.ac.uk

Research groups

Ferreira Group: Quantitative cardiac magnetic resonance myocardial tissue characterisation

Kate Thomson

Clinical Research Fellow

Recent publications

Combined RNA Splicing and Patch-Clamp Analysis Reveal Pathogenicity of Splice-Altering Variants in KCNH2-Related LQTS.
Journal article

Clasper S. et al, (2025), Circ Genom Precis Med
An ALPK3 truncation variant causing autosomal dominant hypertrophic cardiomyopathy is partially rescued by mavacamten.
Journal article

Leinhos L. et al, (2025), Sci Rep, 15
A rare splice-site variant in TNNT2: the need for ancestral diversity in genomic reference data sets.
Journal article

Butters A. et al, (2025), Eur Heart J
Large-scale genome-wide association analyses identify novel genetic loci and mechanisms in hypertrophic cardiomyopathy.
Journal article

Tadros R. et al, (2025), Nat Genet, 57, 530 - 538
Myocardial disarray and fibrosis across hypertrophic cardiomyopathy stages associate with ECG markers of arrhythmic risk.
Journal article

Ashkir Z. et al, (2025), Eur Heart J Cardiovasc Imaging, 26, 218 - 228

More publications